DK0840748T3 - Transformerende vækstfaktor betakrystaller - Google Patents

Transformerende vækstfaktor betakrystaller

Info

Publication number
DK0840748T3
DK0840748T3 DK96927031T DK96927031T DK0840748T3 DK 0840748 T3 DK0840748 T3 DK 0840748T3 DK 96927031 T DK96927031 T DK 96927031T DK 96927031 T DK96927031 T DK 96927031T DK 0840748 T3 DK0840748 T3 DK 0840748T3
Authority
DK
Denmark
Prior art keywords
growth factor
transforming growth
tgf
factor beta
beta
Prior art date
Application number
DK96927031T
Other languages
English (en)
Inventor
Markus Gruetter
Tudor Arvinte
Peer Mittl
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0840748T3 publication Critical patent/DK0840748T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK96927031T 1995-07-25 1996-07-17 Transformerende vækstfaktor betakrystaller DK0840748T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95810484 1995-07-25
PCT/EP1996/003140 WO1997005166A1 (en) 1995-07-25 1996-07-17 Transforming growth factor beta crystals

Publications (1)

Publication Number Publication Date
DK0840748T3 true DK0840748T3 (da) 2003-07-28

Family

ID=8221775

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96927031T DK0840748T3 (da) 1995-07-25 1996-07-17 Transformerende vækstfaktor betakrystaller

Country Status (12)

Country Link
US (1) US6294656B1 (da)
EP (1) EP0840748B1 (da)
JP (1) JP4246795B2 (da)
AT (1) ATE236929T1 (da)
AU (1) AU6700696A (da)
CA (1) CA2225963C (da)
DE (1) DE69627340T2 (da)
DK (1) DK0840748T3 (da)
ES (1) ES2196164T3 (da)
PT (1) PT840748E (da)
WO (1) WO1997005166A1 (da)
ZA (1) ZA966274B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6079213A (en) * 1997-12-12 2000-06-27 Magnetic Imaging Technologies Incorporated Methods of collecting, thawing, and extending the useful life of polarized gases and associated accumulators and heating jackets
US6128918A (en) * 1998-07-30 2000-10-10 Medi-Physics, Inc. Containers for hyperpolarized gases and associated methods
US7622562B2 (en) 2002-06-26 2009-11-24 Zimmer Orthobiologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
CA2512052C (en) 2002-12-31 2016-06-21 Altus Pharmaceuticals Inc. Human growth hormone crystals and methods for preparing them
US20050074453A1 (en) * 2003-10-02 2005-04-07 Ferree Bret A. Methods of preventing adhesions following laminectomies and other surgical procedures
ES2396689T3 (es) 2003-12-11 2013-02-25 Isto Technologies Inc. Sistema de cartílago particulado
JP5292533B2 (ja) 2005-08-26 2013-09-18 ジンマー・インコーポレイテッド インプラントおよび関節疾患の治療、置換および治療方法
GB0604966D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
ES2447516T3 (es) * 2006-12-21 2014-03-12 Stryker Corporation Formulaciones de liberación sostenida que comprenden cristales BMP-7
WO2008128075A1 (en) 2007-04-12 2008-10-23 Isto Technologies, Inc. Compositions and methods for tissue repair
GB0724204D0 (en) * 2007-12-12 2008-01-23 Renovo Ltd Methods for inhibition of scarring
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1126561B (de) 1960-07-05 1962-03-29 Hoechst Ag Verfahren zur Herstellung von mikrokristallinem Insulin
DE2256215C3 (de) 1972-11-16 1981-01-08 Hoechst Ag, 6000 Frankfurt Insulin-Zubereitung mit einem Gehalt an kristallinem Insulin und amorphem Desphenylalanin8' -insulin
EG12098A (en) 1974-04-13 1980-12-31 Hoechst Ag New pharmaceutical insulin preparations having antidiabetic activity and process for their manufacture
DE2933946A1 (de) 1979-08-22 1981-03-12 Hoechst Ag, 6000 Frankfurt Insulinkristallsuspension und verfahren zu ihrer herstellung.
DE3327709A1 (de) 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
DE3327928A1 (de) 1983-08-03 1985-02-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten
DE3606163A1 (de) 1986-02-26 1987-08-27 Hoechst Ag Vorrichtung zur applikation von arzneimittelsuspensionen
EP0347781B1 (de) 1988-06-23 1994-02-16 Hoechst Aktiengesellschaft Mini-Proinsulin, seine Herstellung und Verwendung
US5322933A (en) 1992-05-07 1994-06-21 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Crystal structure of TGF-β-2
CA2149657A1 (en) 1993-09-29 1995-04-06 Billie M. York Compositions containing growth factors and antiplastic agents

Also Published As

Publication number Publication date
JP4246795B2 (ja) 2009-04-02
JP2000502243A (ja) 2000-02-29
PT840748E (pt) 2003-08-29
DE69627340T2 (de) 2004-02-05
ES2196164T3 (es) 2003-12-16
US6294656B1 (en) 2001-09-25
CA2225963C (en) 2008-02-05
CA2225963A1 (en) 1997-02-13
DE69627340D1 (de) 2003-05-15
WO1997005166A1 (en) 1997-02-13
ZA966274B (en) 1997-01-27
EP0840748B1 (en) 2003-04-09
ATE236929T1 (de) 2003-04-15
AU6700696A (en) 1997-02-26
EP0840748A1 (en) 1998-05-13

Similar Documents

Publication Publication Date Title
DE69627340D1 (de) Transformierenden waeckstumsfaktor beta krystalle
IT1182723B (it) Tavoletta di sostanza attiva farmaceutica che si disgrega rapidamente stabili al magazzinaggio
NO170260C (no) Fremstilling av oksygen med hoey renhet
AU627845B2 (en) Improvements in or relating to devices for administration of drugs or the like
KR960009650B1 (en) Sustained release pharmaceutical composition of diltiazem
JO1502B1 (en) New pharmacy vehicles
IT8821535A0 (it) Derivati 4' fosfato di glucosidi della epipodofillotossina e relative composizioni farmaceutiche.
EP0564739A3 (da)
IL88719A0 (en) Novel crystal form of ciclosporin,its production and pharmaceutical compositions containing it
DK680788D0 (da) Indolcarboxylsyreestere og -amider, deres fremstilling of laegemidler indeholdende forbindelserne
ITMI921022A0 (it) Procedimento per la preparazione di una forma liquida stabile di medicamenti contenenti beta-bloccanti con liberazione controllata del principio attivo per la somministrazione orale
DE3583916D1 (de) Waessrige arzneiformulierungen des piroxicammonohydrats.
EP0709395A3 (en) Preparation of Stable Insulin Analog Crystals
ES2075454T3 (es) Forma cristalina pura de rifapentina.
NO168648C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive nitrogenholdige derivater av epipodofyllotoksin-glukosidderivater.
PT86776A (pt) Process for the preparation of piperazinecarboxylic acid and pharmaceutical compositions containing it
HUT50762A (en) Process for production of medical compositions containing as active substance derivatives of pirrol and process for production of the active substance
PT87679A (pt) A process for the preparation of 2-methoxymethyl-penem derivatives and of pharmaceutical compositions containing the same
DE58909140D1 (de) Verwendung stabiler Oxapenem-3-carbonsäuren zur Herstellung Beta-Lactamase hemmender Arzneimittel.
DK560989D0 (da) Anvendelse af ethylendiamintetraeddikesyre til fremstilling af laegemidler
IL85651A (en) Preparation of optically active oxo-isoindolinyl derivatives,some such novel dextrorotary isomers and pharmaceutical compositions containing the novel compounds
PT87593A (pt) Process for the preparation of nucleosides and of pharmaceutical compounds containing them
PT83456A (en) Process for the preparation of pharmaceutical compositions with controlled release of active substance
PT87555A (pt) Process for the preparation and isolation of human splein and of pharmaceutical compounds containing it
SE8704049D0 (sv) Novel pharmacological compounds